chrX-141905540-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005462.5(MAGEC1):c.136G>A(p.Asp46Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,097,901 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005462.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEC1 | NM_005462.5 | c.136G>A | p.Asp46Asn | missense_variant | 4/4 | ENST00000285879.5 | NP_005453.2 | |
MAGEC1 | XM_011531418.3 | c.136G>A | p.Asp46Asn | missense_variant | 4/4 | XP_011529720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEC1 | ENST00000285879.5 | c.136G>A | p.Asp46Asn | missense_variant | 4/4 | 1 | NM_005462.5 | ENSP00000285879 | P3 | |
MAGEC1 | ENST00000406005.2 | c.-122G>A | 5_prime_UTR_variant | 3/4 | 1 | ENSP00000385500 | A2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183267Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67753
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1097901Hom.: 0 Cov.: 35 AF XY: 0.0000193 AC XY: 7AN XY: 363405
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.136G>A (p.D46N) alteration is located in exon 4 (coding exon 2) of the MAGEC1 gene. This alteration results from a G to A substitution at nucleotide position 136, causing the aspartic acid (D) at amino acid position 46 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at